Study to Assess Efficacy and Safety of Bulevirtide in Patients With CHD
Status:
Active, not recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of bulevirtide for treatment
of chronic hepatitis delta (CHD) in comparison to delayed treatment.